NCT02003144 2022-08-23An Open Label Extension Trial of Eculizumab in Relapsing NMO PatientsAlexion Pharmaceuticals, Inc.Phase 3 Completed119 enrolled 17 charts
NCT02276963 2019-06-06Ublituximab for Acute Neuromyelitis Optica (NMO) RelapsesJohns Hopkins UniversityPhase 1 Completed6 enrolled 9 charts
NCT00179478 2017-09-06CHAMPIONS10Beth Israel Deaconess Medical CenterPhase 4 Completed155 enrolled 10 charts